Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Your care team will look at your full picture, including nutrition and activity, before recommending a change
In such cases, healthcare providers might consider alternative treatments or adjunct therapies to achieve better control
Monthly prescriptions for obesity medications reached 1.5 million in February 2024, with semaglutide (Wegovy) and tirzepatide (Zepbound) gaining market share as phentermines dominance declines A recent study published in JAMA Network Open finds a strong link between prescription trends of obesity management medications and public online search activities in the United States
Current availability is limited to research chemical suppliers and clinical trials
US$ 28.30
US$ 22.80
US$ 28.58
US$ 24.96
US$ 21.58
US$ 24.04
US$ 21.99
US$ 21.45
US$ 24.39
US$ 24.18
US$ 25.52
